U.S. Markets open in 8 hrs 26 mins

Fibrogen Inc (FGEN) CEO Thomas B Neff Sold $1.8 million of Shares

CEO of Fibrogen Inc (30-Year Financial, Insider Trades) Thomas B Neff (insider trades) sold 39,636 shares of FGEN on 08/22/2019 at an average price of $44.33 a share. The total sale was $1.8 million.

FibroGen Inc is a biopharmaceutical company. It is engaged in the discovery, development and commercialization of novel therapeutics to treat serious unmet medical needs. FibroGen Inc has a market cap of $3.63 billion; its shares were traded at around $41.72 with and P/S ratio of 17.28. GuruFocus has detected 5 severe warning signs with FibroGen Inc. .

CEO Recent Trades:

  • CEO Thomas B Neff sold 39,636 shares of FGEN stock on 08/22/2019 at the average price of $44.33. The price of the stock has decreased by 5.89% since.
  • CEO Thomas B Neff sold 39,636 shares of FGEN stock on 08/13/2019 at the average price of $45.44. The price of the stock has decreased by 8.19% since.
  • CEO Thomas B Neff sold 39,636 shares of FGEN stock on 07/25/2019 at the average price of $46.74. The price of the stock has decreased by 10.74% since.

Directors and Officers Recent Trades:

  • Director Kalevi Kurkijarvi sold 6,000 shares of FGEN stock on 08/05/2019 at the average price of $45.22. The price of the stock has decreased by 7.74% since.

For the complete insider trading history of FGEN, click here

.This article first appeared on GuruFocus.